BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

ICAD

21.08

-0.57%↓

Search

Gerresheimer AG

Затворен

СекторЗдравеопазване

55.3 2.88

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

52.85

Максимум

55.65

Ключови измерители

By Trading Economics

Приходи

-56M

-17M

Продажби

-49M

520M

P/E

Средно за сектора

22.741

57.333

EPS

0.46

Дивидентна доходност

2.41

Марж на печалбата

-3.363

Служители

13,632

EBITDA

-33M

84M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+83.02% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

2.41%

2.63%

Следващи печалби

10.07.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-40M

1.8B

Предишно отваряне

52.42

Предишно затваряне

55.3

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

Gerresheimer AG Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

4.04.2025 г., 10:15 ч. UTC

Значими двигатели на пазара
Придобивния, сливания и поглъщания

Gerresheimer Shares Fall After Report That KKR Exited Consortium Seeking Bid

4.04.2025 г., 09:39 ч. UTC

Придобивния, сливания и поглъщания

KKR Drops Out of Consortium Attempting Gerresheimer Takeover, Bloomberg Says, Citing Sources

13.05.2024 г., 11:16 ч. UTC

Топ новини

German Companies Bet on AI But Payoff Could Be Years Away -- Talking Markets

Сравнение с други в отрасъла

Ценова промяна

Gerresheimer AG Прогноза

Ценова цел

By TipRanks

83.02% нагоре

12-месечна прогноза

Среден 98.1 EUR  83.02%

Висок 122.5 EUR

Нисък 84.5 EUR

Според 12 анализатори от Wall Street, предложили 12-месечна ценова цел за Gerresheimer AG през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

12 ratings

11

Купи

1

Задържане

0

Продай

Техническа оценка

By Trading Central

53.05 / 53.85Подкрепа & съпротива

Краткосрочен план

Bullish Evidence

Средносрочен план

Strong Bearish Evidence

Дългосрочен план

Neutral Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.